The anesthesia drug, Raplon, manufactured by Organon Pharmaceuticals, was voluntarily removed from the market after it was linked to five patient deaths and many more cases of serious side effects over the last several months. Raplon, which was approved by the Food and Drug Administration in August of 1999, was created